Louisiana 2014 Regular Session

Louisiana House Bill HB514

Introduced
3/10/14  
Introduced
3/10/14  
Refer
3/10/14  
Refer
3/10/14  
Report Pass
3/26/14  
Engrossed
4/7/14  
Refer
4/8/14  
Report Pass
4/29/14  
Enrolled
5/12/14  
Chaptered
5/22/14  

Caption

Restricts the sale of dextromethorphan (EN SEE FISC NOTE LF RV See Note)

Impact

The bill also includes specific provisions that require sellers to verify the age of a purchaser by demanding valid photo identification that confirms the individual is eighteen years or older. The penalties for violating this law include fines for both sellers and minors attempting to make purchases, ensuring a level of enforcement and discouragement against noncompliance. Thus, HB 514 sets a clear legal framework for controlling access to this substance among younger populations, effectively altering existing state laws regarding drug sales to minors.

Summary

House Bill 514 introduces regulations surrounding the sale and purchase of nonprescription products containing dextromethorphan, a cough suppressant commonly found in over-the-counter medications. The bill prohibits any sales of such products to individuals under the age of eighteen. Additionally, it makes it unlawful for minors to attempt to purchase these products. This legislative move aims to mitigate potential misuse of dextromethorphan among minors, as its recreational abuse is a growing concern in public health discussions.

Sentiment

The sentiment surrounding the bill appears largely supportive, as it addresses public health concerns regarding the abuse of over-the-counter medications by minors. Advocates for the bill, including some healthcare and parental advocacy groups, view it as a necessary step in protecting youth and preventing substance abuse. The absence of notable opposition in the voting records suggests a consensus among legislators on the importance of this regulation, though there may still be concerns regarding the implementation and enforcement of age verification requirements.

Contention

A point of contention arises from the bill's provision for state preemption, which means it overrides any local ordinances that may attempt to regulate the sale of dextromethorphan differently. While uniformity in drug regulations is the intended goal, this centralization of authority can be viewed as limiting local governance. Critics may argue that local governments might have better insight into their community's unique challenges and needs regarding drug sales and public health.

Companion Bills

No companion bills found.

Similar Bills

LA HB82

Limits the sale and purchase of products containing dextromethorphan (OR INCREASE GF EX See Note)

LA HSR6

Requests a study of the feasibility and practicality of limiting the sale of products containing dextromethorphan

MA S1617

Prohibiting the sale of dextromethorphan to minors

MA H2226

Prohibiting the sale of dextromethorphan to minors

MA H2481

Prohibiting the sale of dextromethorphan to minors

MA S1456

Prohibiting the sale of dextromethorphan to minors

TX HB1518

Relating to the regulation of the sale of dextromethorphan to minors; providing civil penalties.

TX HB3066

Relating to the regulation of the sale of dextromethorphan to minors; providing civil penalties.